featured
Pembrolizumab vs Chemotherapy in Advanced Esophageal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
J. Clin. Oncol 2020 Oct 07;[EPub Ahead of Print], T Kojima, MA Shah, K Muro, E Francois, A Adenis, CH Hsu, T Doi, T Moriwaki, SB Kim, SH Lee, J Bennouna, K Kato, L Shen, P Enzinger, SK Qin, P Ferreira, J Chen, G Girotto, C de la Fouchardiere, H Senellart, R Al-Rajabi, F Lordick, R Wang, S Suryawanshi, P Bhagia, SP Kang, JP MetgesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.